Synchronous Pleural and Peritoneal Mesothelioma: a Case Report and Narrative Review

被引:0
|
作者
Vilchez, Miguel Enrique Alberto [1 ]
Pachmayr, Eva [1 ]
Arnold, Alexander [2 ]
Guel-Klein, Safak [1 ]
Brandl, Andreas [1 ]
Rau, Beate [1 ]
机构
[1] Charite Univ Med Berlin, Dept Surg, Campus Virchow Klinikum & Charite Campus Mitte, D-13353 Berlin, Germany
[2] Charite Univ Med Berlin, Inst Pathol, Berlin, Germany
关键词
Pleural Mesothelioma; Peritoneal Mesothelioma; Cytoreductive Surgery; Hyperthermic Chemotherapy; HIPEC; HITOC; STAGING PROJECT PROPOSALS; FORTHCOMING 8TH EDITION; MALIGNANT MESOTHELIOMA; CLINICAL PRESENTATION; TNM CLASSIFICATION; IASLC MESOTHELIOMA; PROGNOSTIC-FACTORS; CHEMOTHERAPY; DESCRIPTORS; MANAGEMENT;
D O I
10.1007/s13193-022-01637-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant mesotheliomas most often affect the pleura and tend to spread locally within the originating cavity. Mesotheliomas are already rare diseases, and cases with synchronous pleural and peritoneal involvement are scarce in the literature. Mesothelioma in children is a rare disease representing only 0.9% of all mesotheliomas. They exhibit similar distribution and characteristics as mesotheliomas in adults and generally, a poor prognosis. Due to the rarity, there is no standardized treatment recommendation for children with mesothelioma. Though the malignant mesothelioma tends to spread locally within the originating cavity, pleuM have been reported to metastasize into the peritoneal cavity and vice versa. As there are only few studies concerning the metastatic spread of mesothelioma, it is difficult to define a precise incidence and risk factors for patients to develop metastases of the other mesothelium. There is no standardized therapeutic recommendation for patients with synchronous pleuM and perM. Our patient proved to profit from a radical two-stage surgical approach in combination with locoregional chemotherapy; she showed no sign of tumor recurrences 9 years after tumor resection. In conclusion, clinical studies are needed to confirm the benefit of this treatment and to determine its limitations and selection criteria.
引用
收藏
页码:97 / 105
页数:9
相关论文
共 50 条
  • [1] Synchronous Pleural and Peritoneal Mesothelioma: a Case Report and Narrative Review
    Miguel Enrique Alberto Vilchez
    Eva Pachmayr
    Alexander Arnold
    Safak Gül-Klein
    Andreas Brandl
    Beate Rau
    Indian Journal of Surgical Oncology, 2023, 14 : 97 - 105
  • [2] A synchronous occurrence of breast cancer and pleural mesothelioma: a case report
    Ahmad, Zaheer
    Jehanzeb, Hashir
    Hussain, Saad Noor
    Umar, M.
    Saleem, Humna
    JOURNAL OF MEDICAL CASE REPORTS, 2025, 19 (01)
  • [3] Challenging Diagnostic Process for a Malignant Peritoneal Mesothelioma Patient With Ascites and Pleural Effusion: A Case Report and Review of the Literature
    Zeng, Xiaofeng
    Xu, Ke
    Zhang, Liying
    Huang, Xiaoli
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] A peritoneal, pleural mesothelioma case who has survived for six years
    Kaplan, Murat Bayram
    Koksel, Oguz
    Ayan, Erhan
    Ozdulger, Ali
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 17 (04): : 289 - 292
  • [5] Malignant peritoneal mesothelioma: a review
    Broeckx, Glenn
    Pauwels, Patrick
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (05) : 537 - 542
  • [6] Malignant Peritoneal Mesothelioma : a Case Report
    Vukovic, M.
    Krivokuca, D.
    Moljevic, N.
    ACTA CHIRURGICA BELGICA, 2009, 109 (03) : 408 - 410
  • [7] Pleural mesothelioma - case report
    Klawiter, Anna
    Damaszke, Tomasz
    POLISH JOURNAL OF RADIOLOGY, 2010, 75 (04) : 61 - 63
  • [8] Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report
    Pezzuto, Federica
    Vimercati, Luigi
    Fortarezza, Francesco
    Marzullo, Andrea
    Pennella, Antonio
    Cavone, Domenica
    Punzi, Alessandra
    Caporusso, Concetta
    d'Amati, Antonio
    Lettini, Teresa
    Serio, Gabriella
    DIAGNOSTIC PATHOLOGY, 2021, 16 (01)
  • [9] A review of bevacizumab in the treatment of malignant pleural mesothelioma
    Brosseau, Solenn
    Assoun, Sandra
    Naltet, Charles
    Steinmetz, Christelle
    Gounant, Valerie
    Zalcman, Gerard
    FUTURE ONCOLOGY, 2017, 13 (28) : 2537 - 2546
  • [10] Major response of a peritoneal mesothelioma to nivolumab and ipilimumab: a case report, molecular analysis and review of literature
    Reveneau, Marie-Florence
    Masliah-Planchon, Julien
    Fernandez, Manuel
    Ouikene, Abdenour
    Dron, Bernard
    Dadamessi, Innocenti
    Dayen, Charles
    Golmard, Lisa
    Chauffert, Bruno
    FRONTIERS IN ONCOLOGY, 2024, 14